Buerger's disease cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Buerger's disease}} | {{Buerger's disease}} | ||
{{CMG}};{{AE}}{{HM}} | |||
==References== | ==References== | ||
{{reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category:Cardiovascular diseases]] | [[Category:Cardiovascular diseases]] | ||
[[Category:Angiology]] | [[Category:Angiology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Up-To-Date]] |
Latest revision as of 16:45, 9 April 2018
Buerger's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Buerger's disease cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Buerger's disease cost-effectiveness of therapy |
Risk calculators and risk factors for Buerger's disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]